Ischemic Stroke Associated With Calcitonin Gene-Related Peptide Inhibitor Therapy for Migraine: A Case Report

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

Astrid van Hylckama Vlieg, Frans M. Helmerhorst, Jan P. Vandenbroucke et al. · BMJ · 2009 · 662 citations · Full text

Medicine, Gynecology, Obstetrics +17

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

David W. Dodick, Peter J. Goadsby, Stephen D. Silberstein et al. · The Lancet Neurology · 2014 · 372 citations

Medicine, Neurology, Pharmacology +12

Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study

Faisal Mohammad Amin, Mohammad Sohail Asghar, Anders Hougaard et al. · The Lancet Neurology · 2013 · 291 citations

Medicine, Neurology, Neuroscience +15

Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects

Thuy Vu, Peiming Ma, Jiyun Sunny Chen et al. · Pharmaceutical Research · 2017 · 96 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Who Should Try New Antibody Treatments for Migraine?

Elizabeth Loder, Rebecca Burch · JAMA Neurology · 2018 · 28 citations

Medicine, Neurology, Otolaryngology +6